Literature DB >> 20182667

Clinical and bacteriological characteristics of pyogenic liver abscess in non-diabetic patients.

Han-Chuan Chuang1, Te-Li Chen, Dung-Hung Chiang, Yi-Tzu Lee, Ling-Ju Huang, Fu-Der Wang, Chang-Phone Fung, Cheng-Yi Liu.   

Abstract

BACKGROUND AND
PURPOSE: Diabetes mellitus is an important risk factor for Klebsiella pneumoniae liver abscess, but many patients with pyogenic liver abscess (PLA) do not have diabetes. This study was conducted to compare the clinical characteristics and prognostic factors of K. pneumoniae PLA with that caused by other organisms in non-diabetic patients.
METHODS: The medical charts of patients with a diagnosis of PLA were retrospectively reviewed from January 2005 to December 2007. The clinical symptoms and signs, laboratory data, and risk factors were analyzed.
RESULTS: There were 50 patients in the K. pneumoniae group and 34 patients in the non-K. pneumoniae group. The clinical presentations did not differ between the 2 groups. The patients in the non-K. pneumoniae group had a higher prevalence of malignant disease than those in the K. pneumoniae group (58.8% vs 6.0%; p < 0.001). Non-K. pneumoniae PLA was strongly associated with hepatobiliary tumor (p = 0.015). Among the non-K. pneumoniae isolates, Escherichia coli was the most common pathogen (n = 20; 58.8%). Forty seven K. pneumoniae isolates (94%) were susceptible to all tested antimicrobial agents except ampicillin, while the non-K. pneumoniae Gram-negative pathogens had greater resistance to first-generation cephalosporins. Poor prognostic factors included chronic renal failure (p = 0.005), abscess rupture (p = 0.036), and right lower lung infiltration (p = 0.049).
CONCLUSIONS: Hepatobiliary malignancy and newly diagnosed malignancy were risk factors for non-K. pneumoniae liver abscess in non-diabetic patients. Physicians should ascertain the presence of underlying malignancy in patients with non-K. pneumoniae PLA.

Entities:  

Mesh:

Year:  2009        PMID: 20182667

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  7 in total

1.  Pyogenic liver abscess caused by Fusobacterium in a 21-year-old immunocompetent male.

Authors:  Zohair Ahmed; Saurabh K Bansal; Sonu Dhillon
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  Emerging severe and fatal infections due to Klebsiella pneumoniae in two university hospitals in France.

Authors:  Dominique Decré; Charlotte Verdet; Aurélie Emirian; Thibault Le Gourrierec; Jean-Claude Petit; Georges Offenstadt; Eric Maury; Sylvain Brisse; Guillaume Arlet
Journal:  J Clin Microbiol       Date:  2011-06-15       Impact factor: 5.948

3.  Structure and immunological characterization of the capsular polysaccharide of a pyrogenic liver abscess caused by Klebsiella pneumoniae: activation of macrophages through Toll-like receptor 4.

Authors:  Feng-Ling Yang; Yu-Liang Yang; Pei-Chun Liao; Ju-Ching Chou; Keng-Chang Tsai; An-Suei Yang; Fuu Sheu; Tzu-Lung Lin; Pei-Fang Hsieh; Jin-Town Wang; Kuo-Feng Hua; Shih-Hsiung Wu
Journal:  J Biol Chem       Date:  2011-04-08       Impact factor: 5.157

4.  Fusobacterium necrophorum: a rare cause of hepatic abscess in an immunocompetent individual.

Authors:  Eduard Fatakhov; Maharsh K Patel; Savini Santha; Christopher F Koch
Journal:  BMJ Case Rep       Date:  2013-08-20

5.  Identification of a capsular variant and characterization of capsular acetylation in Klebsiella pneumoniae PLA-associated type K57.

Authors:  Chun-Ru Hsu; Chun-Hsing Liao; Tzu-Lung Lin; Han-Ru Yang; Feng-Ling Yang; Pei-Fang Hsieh; Shih-Hsiung Wu; Jin-Town Wang
Journal:  Sci Rep       Date:  2016-08-23       Impact factor: 4.379

6.  A Rare Case of Fusobacterium Necrophorum Liver Abscesses.

Authors:  Faris Hannoodi; Hussam Sabbagh; Zain Kulairi; Sarwan Kumar
Journal:  Clin Pract       Date:  2017-01-12

7.  Does pyogenic liver abscess increase the risk of delayed-onset primary liver cancer?: Evidence from a nationwide cohort study.

Authors:  Chia-Sheng Chu; Che-Chen Lin; Cheng-Yuan Peng; Po-Heng Chuang; Wen-Pang Su; Shih-Wei Lai; Hsuan-Ju Chen; Chi-Jung Chung; Hsueh-Chou Lai
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.